Freshworks (FRSH) 10-Q 31 Oct 23 2023 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2023	Oct. 27, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	001-40806
Entity Registrant Name	Freshworks Inc.
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	2950 S Delaware Street
Entity Address, Address Line Two	Suite 201
Entity Address, City or Town	San Mateo
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94403
Entity Tax Identification Number	33-1218825
City Area Code	650
Local Phone Number	513-0514
Title of 12(b) Security	Class A common stock, par value $0.00001 per share
Trading Symbol	FRSH
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001544522
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		202,142,733
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		93,146,624

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 458,249	$ 304,083
Marketable securities	706,472	843,405
Accounts receivable, net of allowance of $7,003 and $6,628	80,294	70,470
Deferred contract acquisition costs	22,155	20,139
Prepaid expenses and other current assets	52,331	38,913
Total current assets	1,319,501	1,277,010
Property and equipment, net	22,928	24,139
Operating lease right-of-use assets	32,246	33,024
Deferred contract acquisition costs, noncurrent	19,067	19,536
Goodwill	6,181	6,181
Deferred tax assets	8,535	8,689
Other assets	9,630	11,637
Total assets	1,418,088	1,380,216
Current liabilities:
Accounts payable	2,688	5,908
Accrued liabilities	54,664	59,008
Deferred revenue	246,085	205,626
Income tax payable	2,284	1,150
Total current liabilities	305,721	271,692
Operating lease liabilities, non-current	26,949	28,174
Other liabilities	26,934	28,532
Total liabilities	359,604	328,398
Commitments and contingencies (Note 7)
Stockholders' equity:
Preferred Stock, value	0	0
Additional paid-in capital	4,675,801	4,562,319
Accumulated other comprehensive loss	(4,892)	(7,431)
Accumulated deficit	(3,612,428)	(3,503,073)
Total stockholders' equity	1,058,484	1,051,818
Total liabilities and stockholders' equity	1,418,088	1,380,216
Class A Common Stock
Stockholders' equity:
Common stock, value	2	2
Class B Common Stock
Stockholders' equity:
Common stock, value	$ 1	$ 1

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Accounts receivable, allowance for credit loss, current	$ 7,003	$ 6,628
Preferred stock, par value (in USD per share)	$ 0.00001	$ 0.00001
Preferred stock, authorized (in shares)	10,000,000	10,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Class A Common Stock
Common stock, par value (in USD per share)	$ 0.00001	$ 0.00001
Common stock, authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, issued (in shares)	201,798,721	162,825,075
Common stock, outstanding (in shares)	201,798,721	162,825,075
Class B Common Stock
Common stock, par value (in USD per share)	$ 0.00001	$ 0.00001
Common stock, authorized (in shares)	350,000,000	350,000,000
Common stock, issued (in shares)	93,062,334	126,268,150
Common stock, outstanding (in shares)	93,062,334	126,268,150

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Revenue	$ 153,550	$ 128,760	$ 436,321	$ 364,829
Cost of revenue	26,263	24,179	76,360	70,616
Gross profit	127,287	104,581	359,961	294,213
Operating expense:
Research and development	34,885	35,871	101,922	100,885
Sales and marketing	90,673	86,865	265,458	248,369
General and administrative	40,464	40,133	122,712	117,723
Total operating expenses	166,022	162,869	490,092	466,977
Loss from operations	(38,735)	(58,288)	(130,131)	(172,764)
Interest and other income, net	10,993	2,249	31,688	2,609
Loss before income taxes	(27,742)	(56,039)	(98,443)	(170,155)
Provision for income taxes	3,291	1,804	10,912	6,500
Net loss	$ (31,033)	$ (57,843)	$ (109,355)	$ (176,655)
Net loss per share - basic (in dollars per share)	$ (0.11)	$ (0.20)	$ (0.37)	$ (0.62)
Net loss per share - diluted (in dollars per share)	$ (0.11)	$ (0.20)	$ (0.37)	$ (0.62)
Weighted-average shares used in computing net loss per share - basic (in shares)	294,146	286,697	292,103	283,258
Weighted-average shares used in computing net loss per share - diluted (in shares)	294,146	286,697	292,103	283,258

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (31,033)	$ (57,843)	$ (109,355)	$ (176,655)
Other comprehensive income (loss):
Change in unrealized loss on marketable securities	1,483	(2,481)	3,169	(8,043)
Net change on cash flow hedges	(734)	0	(630)	0
Total other comprehensive income (loss)	749	(2,481)	2,539	(8,043)
Comprehensive loss	$ (30,284)	$ (60,324)	$ (106,816)	$ (184,698)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		273,294,000
Beginning balance at Dec. 31, 2021	$ 1,238,039	$ 3	$ 4,509,724	$ (747)	$ (3,270,941)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		389,000
Issuance of common stock upon exercise of stock options	106		106
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for taxes (in shares)		12,889,000
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for taxes	$ (152,330)		(152,330)
Issuance of common stock under employee stock purchase plan, net of shares withheld for taxes (in shares)	510,093	510,000
Issuance of common stock under employee stock purchase plan, net of shares withheld and retired for taxes	$ 6,959		6,959
Stock-based compensation	151,927		151,927
Other comprehensive income (loss)	(8,043)			(8,043)
Net loss	(176,655)				(176,655)
Ending balance (in shares) at Sep. 30, 2022		287,082,000
Ending balance at Sep. 30, 2022	1,060,003	$ 3	4,516,386	(8,790)	(3,447,596)
Beginning balance (in shares) at Jun. 30, 2022		285,558,000
Beginning balance at Jun. 30, 2022	1,079,610	$ 3	4,475,669	(6,309)	(3,389,753)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		34,000
Issuance of common stock upon exercise of stock options	3		3
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for taxes (in shares)		1,490,000
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for taxes	(13,230)		(13,230)
Stock-based compensation	53,944		53,944
Other comprehensive income (loss)	(2,481)			(2,481)
Net loss	(57,843)				(57,843)
Ending balance (in shares) at Sep. 30, 2022		287,082,000
Ending balance at Sep. 30, 2022	1,060,003	$ 3	4,516,386	(8,790)	(3,447,596)
Beginning balance (in shares) at Dec. 31, 2022		289,093,000
Beginning balance at Dec. 31, 2022	$ 1,051,818	$ 3	4,562,319	(7,431)	(3,503,073)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	205,000	205,000
Issuance of common stock upon exercise of stock options	$ 61		61
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for taxes (in shares)		5,196,000
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for taxes	$ (52,380)		(52,380)
Issuance of common stock under employee stock purchase plan, net of shares withheld for taxes (in shares)	367,319	367,000
Issuance of common stock under employee stock purchase plan, net of shares withheld and retired for taxes	$ 4,312		4,312
Stock-based compensation	161,489		161,489
Other comprehensive income (loss)	2,539			2,539
Net loss	(109,355)				(109,355)
Ending balance (in shares) at Sep. 30, 2023		294,861,000
Ending balance at Sep. 30, 2023	1,058,484	$ 3	4,675,801	(4,892)	(3,612,428)
Beginning balance (in shares) at Jun. 30, 2023		292,839,000
Beginning balance at Jun. 30, 2023	1,057,653	$ 3	4,644,686	(5,641)	(3,581,395)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		61,000
Issuance of common stock upon exercise of stock options	16		16
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for taxes (in shares)		1,961,000
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for taxes	(24,510)		(24,510)
Stock-based compensation	55,609		55,609
Other comprehensive income (loss)	749			749
Net loss	(31,033)				(31,033)
Ending balance (in shares) at Sep. 30, 2023		294,861,000
Ending balance at Sep. 30, 2023	$ 1,058,484	$ 3	$ 4,675,801	$ (4,892)	$ (3,612,428)

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Cash Flows from Operating Activities:
Net loss	$ (31,033)	$ (57,843)	$ (109,355)	$ (176,655)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization			9,098	8,574
Amortization of deferred contract acquisition costs	6,131	4,625	17,600	13,321
Non-cash lease expense			5,692	4,463
Stock-based compensation			160,067	150,652
Premium (discount) amortization on marketable securities			(12,108)	564
Change in fair value of equity securities			(65)	(75)
Deferred income taxes			113	309
Other			175	1,468
Changes in operating assets and liabilities:
Accounts receivable			(10,003)	(5,256)
Deferred contract acquisition costs			(19,147)	(19,554)
Prepaid expenses and other assets			(11,793)	(12,374)
Accounts payable			(3,219)	(1,962)
Accrued and other liabilities			(3,150)	3,874
Deferred revenue			40,459	30,796
Operating lease liabilities			(9,052)	(7,837)
Net cash provided by (used in) operating activities			55,312	(9,692)
Cash Flows from Investing Activities:
Purchases of property and equipment			(990)	(5,288)
Proceeds from sale of property and equipment			91	132
Capitalized internal-use software			(5,075)	(3,828)
Purchases of marketable securities			(653,679)	(538,501)
Sales of marketable securities			0	92,786
Maturities and redemptions of marketable securities			805,933	293,625
Net cash provided by (used in) investing activities			146,280	(161,074)
Cash Flows from Financing Activities:
Proceeds from issuance of common stock under employee stock purchase plan, net			4,312	7,011
Proceeds from exercise of stock options			61	98
Payment of withholding taxes on net share settlement of equity awards			(51,782)	(151,716)
Payment of deferred offering costs			0	(109)
Net cash used in financing activities			(47,409)	(144,716)
Net increase (decrease) in cash, cash equivalents and restricted cash			154,183	(315,482)
Cash, cash equivalents and restricted cash, beginning of period			304,158	747,864
Cash, cash equivalents and restricted cash, end of period	458,341	432,382	458,341	432,382
Reconciliation of cash, cash equivalents and restricted cash to consolidated balance sheets:
Cash and cash equivalents	458,249	432,313	458,249	432,313
Restricted cash included in prepaid expenses and other current assets	0	3	0	3
Restricted cash included in other assets	92	66	92	66
Total cash, cash equivalents and restricted cash	458,341	432,382	458,341	432,382
Supplemental cash flow information:
Cash paid for taxes			9,893	9,550
Non-cash investing and financing activities:
Operating lease right-of-use assets obtained in exchange for operating lease obligations	4,914	1,749	4,914	8,968
Stock-based compensation capitalized as internal-use software	$ 484	$ 52	$ 1,422	$ 1,275

Business, Basis of Presentation

Business, Basis of Presentation and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business, Basis of Presentation and Summary of Significant Accounting Policies	1. Business, Basis of Presentation and Summary of Significant Accounting Policies Description of Business Freshworks Inc. (Freshworks, or the Company) is a software development company that provides modern software-as-a-service (SaaS) products that are designed with the user in mind. The Company was incorporated in Delaware in 2010 and is headquartered in San Mateo, California. Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP). The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, and all intercompany balances and transactions have been eliminated in consolidation. Unaudited Interim Consolidated Financial Statement s The accompanying condensed consolidated balance sheet as of September 30, 2023, the condensed consolidated statements of operations, of comprehensive loss, of cash flows, and of stockholders’ equity for the three and nine months ended September 30, 2023 and 2022, and the related notes to such condensed consolidated financial statements are unaudited. These unaudited condensed consolidated financial statements are presented in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (SEC) and do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with GAAP. In management’s opinion, the unaudited condensed consolidated financial statements have been prepared on a basis consistent with the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of September 30, 2023 and its results of operations and cash flows for the three and nine months ended September 30, 2023 and 2022. The results of operations for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period. The condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the SEC on February 23, 2023. Use of Estimates The preparation of the condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of income and expense during the reporting periods. Significant items subject to such estimates and assumptions include, but are not limited to, the following: • determination of standalone selling price (SSP) for each distinct performance obligation included in customer contracts with multiple performance obligations; • allowance for doubtful accounts; • expected benefit period of deferred contract acquisition costs; • capitalization of internal-use software development costs; • fair value of goodwill; • useful lives of long-lived assets; • valuation of deferred tax assets; • valuation of employee defined benefit plan; • fair value of share-based awards, including performance-based awards; and • incremental borrowing rate used for operating leases. Concentrations of Risk Financial instruments that potentially expose the Company to significant concentration of credit risk consist primarily of cash, cash equivalents, marketable securities, and accounts receivable. The Company’s cash, cash equivalents and marketable securities are generally held with large financial institutions and are in excess of the federally insured limits provided on such deposits. In addition, the Company has cash and cash equivalents held in international bank accounts, which are denominated primarily in Euros, British Pounds, and Indian Rupees. There were no customers that individually exceeded 10% of the Company’s revenue for the three and nine months ended September 30, 2023 and 2022 or that represented 10% or more of the Company’s consolidated accounts receivable balance as of September 30, 2023. The Company primarily relies upon its third-party cloud infrastructure partner, Amazon Web Services, to serve customers and operate certain aspects of its services. Any disruption of this cloud infrastructure partner would impact the Company's operations and its business could be adversely impacted. Significant Accounting Policies The Company's significant accounting policies are described in the Annual Report on Form 10-K for the year ended December 31, 2022. There have been no significant changes to these policies that have had a material impact on the condensed consolidated financial statements and the related notes for the three and nine months ended September 30, 2023. However, starting in 2023, the Company entered into foreign exchange forward contracts to hedge a portion of its forecasted foreign currency expenses and while the impact of the Company's derivative instruments is not material to its condensed consolidated financial statements, the accounting policy on Derivative Instruments is discussed below. Derivative Instruments The Company enters into foreign currency forward contracts, most of which were designated as cash flow hedges, in order to manage the volatility of cash flows that relate to cost of revenues and operating expenses denominated in Indian Rupee. All derivative instruments are measured at fair value based upon quoted market prices for comparable instruments and as such, classified within Level 2 of the fair value hierarchy. Derivative assets and liabilities are presented on a gross basis on the condensed consolidated balance sheets under prepaid expenses and other current assets and accrued liabilities, respectively. Gains or losses related to cash flow hedges are recorded as a component of accumulated other comprehensive income (AOCI) on the condensed consolidated statements of stockholders' equity until the forecasted transaction occurs in earnings. When the forecasted transaction occurs, the related gains and losses are reclassified into earnings within the financial statement line item associated with the underlying hedged transaction. If the underlying hedged transaction does not occur, or it becomes probable that the hedged transaction will not occur, the cumulative unrealized gain or loss is reclassified immediately from AOCI into earnings within interest and other income. Changes in the fair value of currency forward exchange contracts due to changes in time value were excluded from the assessment of effectiveness. The initial value of this excluded component is amortized on a straight-line basis over the life of the hedging instrument and recognized in the f inancial statement line item to which the hedge relates. A majority of the balance related to foreign exchange derivative instruments included in AOCI at September 30, 2023 is expected to be reclassified into earnings within 12 months. Derivative instruments are classified in the condensed consolidated statements of cash flows as cash from operating activities, which reflect the classification of the underlying hedged transactions. The Company does not use derivative financial instruments for trading or speculative purposes. As of September 30, 2023, the total notional amount of outstanding designated foreign currency forward contracts was $49.4 million. The fair value of derivative assets and liabilities as of September 30, 2023, and all related unrealized and realized gains and losses during the three and nine months ended September 30, 2023, were not material. Entering into derivative instruments exposes the Company to credit risk to the extent that the counterparties are unable to meet the terms of the contract. The Company mitigates this credit risk by transacting with major financial institutions with high credit ratings. In addition, the Company has entered into master netting arrangements that mitigate credit risk by permitting net settlement of transactions. As such, the Company's exposure is not considered significant. The Company does not have any collateral requirements with its counterparties. Recent Accounting Pronouncements There have been no recently issued accounting pronouncements that are expected to have a material impact on the Company's condensed consolidated financial statements.

Revenue From Contracts with Cus

Revenue From Contracts with Customers	9 Months Ended
	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Revenue From Contracts with Customers	2. Revenue From Contracts with Customers The Company derives revenue from subscription fees and related professional services. The Company sells subscriptions for its cloud-based solutions directly to customers and indirectly through channel partners through arrangements that are non-cancelable and non-refundable. The Company’s subscription arrangements do not provide customers with the right to take possession of the software supporting the solutions and, as a result, are accounted for as service arrangements. The Company records revenue net of sales or value-added taxes. Disaggregation of Revenue The following table summarizes revenue by the Company’s service offerings (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Subscription services $ 150,033 $ 125,508 $ 425,755 $ 355,298 Professional services 3,517 3,252 10,566 9,531 Total revenue $ 153,550 $ 128,760 $ 436,321 $ 364,829 See Note 11 for revenue by geographic location. Deferred Revenue and Remaining Performance Obligations Deferred revenue consists of customer billings in advance of revenue being recognized from the Company’s subscription and professional services arrangements. Revenue recognized during the three months ended September 30, 2023 and 2022 from amounts included in deferred revenue at the beginning of these periods was $109.5 million and $86.2 million, respectively. Revenue recognized during the nine months ended September 30, 2023 and 2022 from amounts included in deferred revenue at the beginning of these periods was $192.6 million and $146.9 million, respectively. The aggregate balance of remaining performance obligations as of September 30, 2023 was $375.8 million. The Company expects to recognize $285.0 million of the balance as revenue in the next 12 months and the remainder thereafter. The aggregate balance of remaining performance obligations represents contracted revenue that has not yet been recognized, which includes unearned revenue and unbilled amounts that will be recognized as revenue in future periods. As of September 30, 2023, remaining performance obligations comprised $246.1 million of deferred revenue and $129.7 million of unbilled revenue. Deferred Contract Acquisition Costs The change in the balance of deferred contract acquisition costs during the periods presented is as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Balance at beginning of the period $ 40,962 $ 33,592 $ 39,675 $ 29,647 Add: Contract costs capitalized during the period 6,391 6,913 19,147 19,554 Less: Amortization of contract costs during the period (6,131) (4,625) (17,600) (13,321) Balance at end of the period $ 41,222 $ 35,880 $ 41,222 $ 35,880

Cash Equivalents and Marketable

Cash Equivalents and Marketable Securities	9 Months Ended
	Sep. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Cash Equivalents and Marketable Securities	3. Cash Equivalents and Marketable Securities Cash equivalents and available-for-sale debt securities consisted of the following as of September 30, 2023 and December 31, 2022 (in thousands): September 30, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Money market funds $ 99,040 $ — $ — $ 99,040 U.S. treasury securities 213,036 26 — 213,062 U.S. government agency securities 3,939 — — 3,939 Corporate debt securities 50,965 — — 50,965 Total cash equivalents 366,980 26 — 367,006 Debt securities: U.S. treasury securities 240,562 10 (1,197) 239,375 U.S. government agency securities 411,279 — (2,707) 408,572 Corporate debt securities 57,367 — (395) 56,972 Total debt securities 709,208 10 (4,299) 704,919 Total cash equivalents and debt securities $ 1,076,188 $ 36 $ (4,299) $ 1,071,925 December 31, 2022 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Money market funds $ 219,512 $ — $ — $ 219,512 U.S. treasury securities 13,912 3 — 13,915 U.S. government agency securities 10,417 2 — 10,419 Corporate debt securities 1,995 1 — 1,996 Total cash equivalents 245,836 6 — 245,842 Debt securities: U.S. treasury securities 441,909 36 (3,160) 438,785 U.S. government agency securities 301,009 35 (3,531) 297,513 Corporate debt securities 106,436 — (817) 105,619 Total debt securities 849,354 71 (7,508) 841,917 Total cash equivalents and debt securities $ 1,095,190 $ 77 $ (7,508) $ 1,087,759 The following table presents gross unrealized losses and fair values for the securities that were in a continuous unrealized loss position as of September 30, 2023 and December 31, 2022 (in thousands): September 30, 2023 Less than 12 months Greater than 12 months Total Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury securities $ 103,977 $ (584) $ 51,150 $ (613) $ 155,127 $ (1,197) U.S. government agency securities 291,639 (1,588) 111,008 (1,119) 402,647 (2,707) Corporate debt securities 24,336 (228) 14,803 (167) 39,139 (395) Total $ 419,952 $ (2,400) $ 176,961 $ (1,899) $ 596,913 $ (4,299) December 31, 2022 Less Than 12 Months 12 Months or Greater Total Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury securities $ 190,820 $ (1,794) $ 105,115 $ (1,366) $ 295,935 $ (3,160) U.S. government agency securities 220,766 (2,245) 42,754 (1,286) 263,520 (3,531) Corporate debt securities 30,485 (455) 22,864 (362) 53,349 (817) Total $ 442,071 $ (4,494) $ 170,733 $ (3,014) $ 612,804 $ (7,508) The amortized cost and fair value of the available-for-sale debt securities based on contractual maturities are as follows (in thousands): September 30, 2023 Amortized Cost Fair Value Due within one year $ 485,733 $ 482,997 Due after one year but within five years 223,475 221,922 Total $ 709,208 $ 704,919 Accrued interest receivable of $4.0 million and $2.8 million was classified in prepaid expenses and other current assets in the condensed consolidated balance sheet as of September 30, 2023 and December 31, 2022, respectively. In addition to available-for-sale debt securities, marketable securities also include term bond mutual funds, which are measured at fair value. As of September 30, 2023 and December 31, 2022, the fair value of the term bond mutual funds was $1.6 million and $1.5 million, respectively. The change in fair value of the term bond mutual funds is recorded in interest and other income, net in the condensed consolidated statements of operations. The realized and unrealized gains recognized in the condensed consolidated statements of operations for the term bond mutual funds were not material during the three and nine months ended September 30, 2023 and 2022.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	4. Fair Value Measurements The Company measures its financial assets at fair value each reporting period using a fair value hierarchy that prioritizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows: Level 1 —Inputs are observable and reflect quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 —Inputs other than quoted prices included within Level 1 that are observable, either directly or indirectly. Level 3 —Inputs that are unobservable. Money market funds and U.S. treasury securities are classified within Level 1 because they are valued using quoted market prices or alternative pricing sources and models utilizing market observable inputs. Other debt securities and investments are classified within Level 2 if the investments are valued using model driven valuations which use observable inputs such as quoted market prices, benchmark yields, reported trades, broker/dealer quotes or alternative pricing sources with reasonable levels of price transparency. Available-for-sale debt securities are held by custodians who obtain investment prices from a third-party pricing provider that incorporates standard inputs in various asset price models. The Company did not have any assets or liabilities subject to fair value remeasurement on a nonrecurring basis as of September 30, 2023 and December 31, 2022. Assets and Liabilities Measured at Fair Value on a Recurring Basis The following table represents the fair value hierarchy for the Company’s financial assets measured at fair value on a recurring basis as of September 30, 2023 and December 31, 2022 (in thousands): September 30, 2023 Fair Value Measured Using Level 1 Level 2 Total Financial assets: Cash equivalents: Money market funds $ 99,040 $ — $ 99,040 U.S. treasury securities 213,062 — 213,062 U.S. government agency securities — 3,939 3,939 Corporate debt securities — 50,965 50,965 Marketable securities: U.S. treasury securities 239,375 — 239,375 U.S. government agency securities — 408,572 408,572 Corporate debt securities — 56,972 56,972 Term bond mutual funds — 1,553 1,553 Total financial assets $ 551,477 $ 522,001 $ 1,073,478 December 31, 2022 Fair Value Measured Using Level 1 Level 2 Total Financial assets: Cash equivalents: Money market funds $ 219,512 $ — $ 219,512 U.S. treasury securities 13,915 — 13,915 U.S. government agency securities — 10,419 10,419 Corporate debt securities — 1,996 1,996 Marketable securities: U.S. treasury securities 438,785 — 438,785 U.S. government agency securities — 297,513 297,513 Corporate debt securities — 105,619 105,619 Term bond mutual funds — 1,488 1,488 Total financial assets $ 672,212 $ 417,035 $ 1,089,247

Balance Sheet Components

Balance Sheet Components	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Components	5. Balance Sheet Components Property and Equipment, net The following table summarizes property and equipment, net as of September 30, 2023 and December 31, 2022 (in thousands): September 30, 2023 December 31, 2022 Computers $ 16,743 $ 16,552 Capitalized internal-use software 26,728 20,230 Office equipment 4,096 3,744 Furniture and fixtures 8,886 8,881 Motor vehicles 872 1,158 Leasehold improvements 5,729 5,654 Construction in progress 159 224 Total property and equipment 63,213 56,443 Less: accumulated depreciation and amortization (40,285) (32,304) Property and equipment, net $ 22,928 $ 24,139 Capitalization of costs associated with internal-use software were $2.0 million and $1.2 million for the three months ended September 30, 2023 and 2022, respectively; and $6.5 million and $5.1 million for the nine months ended September 30, 2023 and 2022, respectively. Amortization expense of capitalized internal-use software was $1.3 million and $0.9 million for the three months ended September 30, 2023 and 2022, respectively; and $3.7 million and $2.4 million for the nine months ended September 30, 2023 and 2022, respectively. As of September 30, 2023 and December 31, 2022, the net carrying value of capitalized internal-use software was $14.0 million and $11.2 million, respectively. Depreciation expense was $1.7 million for each of the three months ended September 30, 2023 and 2022, respectively; and $5.1 million and $4.9 million for the nine months ended September 30, 2023 and 2022, respectively. Accrued Liabilities The following table summarizes accrued liabilities as of September 30, 2023 and December 31, 2022 (in thousands): September 30, 2023 December 31, 2022 Accrued compensation $ 18,239 $ 20,192 Accrued third-party cloud infrastructure expenses — 2,752 Accrued reseller commissions 8,434 7,731 Accrued advertising and marketing expenses 3,902 4,465 Advanced payments from customers 4,295 3,480 Accrued taxes 8,242 7,730 Operating lease liabilities, current 3,862 6,775 Contributions withheld for employee stock purchase plan 2,854 1,546 Other accrued expenses 4,836 4,337 Total accrued liabilities $ 54,664 $ 59,008 Noncurrent liabilities include $21.3 million and $23.3 million of long term accrued compensation as of September 30, 2023 and December 31, 2022, respectively.

Leases

Leases	9 Months Ended
	Sep. 30, 2023
Leases [Abstract]
Leases	6. Leases The Company has operating leases primarily for office space. The leases have remaining lease terms of one The following table presents various components of the lease costs (in thousands): Operating Leases Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Operating lease cost $ 2,652 $ 2,147 $ 7,644 $ 6,026 Short-term lease cost 76 250 322 907 Variable lease cost 823 660 2,394 2,098 The weighted-average remaining term of the Company's operating leases and the weighted-average discount rate used to measure the present value of the operating lease liabilities are as follows: Lease Term and Discount Rate September 30, 2023 September 30, 2022 Weighted-average remaining lease term (in years) 5.1 5.0 Weighted-average discount rate 8.7 % 7.3 % The following table presents supplemental information arising from lease transactions. Cash payments related to short-term leases are not included in the measurement of the operating lease liabilities, and as such, are excluded from the amounts below (in thousands): Three Months Ended September 30, Nine Months Ended September 30, Supplemental Cash Flow Information: 2023 2022 2023 2022 Cash payments included in the measurement of operating lease liabilities $ 4,472 $ 3,126 $ 10,879 $ 7,400 Operating right-of-use ("ROU") assets obtained in exchange for lease obligations 4,914 1,749 4,914 8,968 As of September 30, 2023, maturities of the operating lease liabilities are as follows (in thousands): Operating Leases Remainder of 2023 $ 253 2024 8,675 2025 9,555 2026 6,356 2027 5,131 Thereafter 10,417 Total lease payments 40,387 Less: imputed interest (9,576) Present value of operating lease liabilities $ 30,811

Commitment and Contingencies

Commitment and Contingencies	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	7. Commitments and Contingencies Other Contractual Commitments The Company's other contractual commitments primarily consist of third-party cloud infrastructure agreements and service subscription purchase arrangements used to support operations at the enterprise level. As of September 30, 2023, other contractual commitments totaling $73.7 million remain outstanding under these agreements through 2025. Litigation and Loss Contingencies On November 1, 2022, a purported Company stockholder filed a securities class action complaint in the U.S. District Court for the Northern District of California against the Company, certain of its current officers and directors, and underwriters of the Company's initial public offering (IPO). On April 14, 2023, the court-appointed lead plaintiff filed a consolidated amended class action complaint. The complaint alleges that defendants violated Sections 11, 12(a)(2), and 15 of the Securities Act of 1933 by making material misstatements or omissions in offering documents filed in connection with the IPO. The complaint seeks unspecified damages, interest, fees, costs, and rescission on behalf of purchasers and/or acquirers of common stock issued in the IPO. On September 28, 2023, the court issued an order granting in part and denying in part defendants' motion to dismiss. The Company and the other defendants intend to vigorously defend against the remaining claims in this action. On March 20, 2023, a purported stockholder derivative complaint was filed in the U.S. District Court for the Northern District of California. The complaint names as defendants the Company’s current directors, as well as the Company, as nominal defendant, and asserts state and federal claims based on some of the same alleged misstatements as the securities class action complaint. The derivative complaint seeks unspecified damages, attorneys’ fees, and other costs. On June 21, 2023, the court stayed the case in light of the pending securities class action. On October 16, 2023, the court extended the stay of the case in light of the pending securities class action. The Company and the other defendants intend to vigorously defend against the claims in this action. From time to time, the Company has been and may be in the future subject to other legal proceedings, claims, investigations, and government inquiries (collectively, legal proceedings) in the ordinary course of business. It has received and may receive claims from third parties asserting, among other things, infringement of their intellectual property rights, defamation, labor and employment rights, privacy, and contractual rights. There are no currently pending legal proceedings that the Company believes will have a material adverse impact on the business or condensed consolidated financial statements. Indemnifications In the ordinary course of business, the Company enters into contractual arrangements under which the Company agrees to provide indemnification of varying scope and terms to customers, business partners, and other parties with respect to certain matters, including losses arising out of intellectual property infringement claims made by third parties, if the Company has violated applicable laws, if the Company is negligent or commits acts of willful misconduct, and other liabilities with respect to its products and services and its business. In these circumstances, payment is typically conditional on the other party making a claim pursuant to the procedures specified in the particular contract. The Company also indemnifies certain of its officers, directors and certain key employees while they are serving in good faith in their respective capacities. To date, the Company has not incurred any material costs as a result of such indemnifications and has not accrued any liabilities related to such obligations in its condensed consolidated financial statements.

Stockholders' Equity and Stock

Stockholders' Equity and Stock Based Compensation	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Stockholders' Equity and Stock-Based Compensation	8. Stockholders' Equity and Stock-Based Compensation Equity Compensation Plans In August 2021, the board of directors (the Board) adopted the 2021 Equity Incentive Plan (the 2021 Plan) and the 2021 Employee Stock Purchase Plan (ESPP), effective upon the IPO. Pursuant to the 2021 Plan, the Board may grant incentive stock options to purchase shares of the Company’s common stock, non-statutory stock options to purchase shares of the Company’s common stock, stock appreciation rights, restricted stock, restricted stock units (RSUs), performance awards (PRSUs) and other awards. The ESPP enables eligible employees to purchase shares of the Company's Class A common stock. Both the 2021 Plan and ESPP include an automatic increase to their shares reserve on January 1 of each year as set forth in the respective plan documents. In August 2022, the Compensation Committee of the Board adopted the 2022 Inducement Plan (the Inducement Plan) in accordance with Listing Rule 5635(c)(4) of the Nasdaq Stock Market. Under the Inducement Plan, nonstatutory stock options, stock appreciation rights, restricted stock, RSUs, PRSUs and other awards may be granted as an inducement material to an eligible person's entering into employment with the Company. Shares of common stock reserved for future issuance were as follows (in thousands): September 30, 2023 2011 Stock Plan: Options, RSUs and PRSUs outstanding 14,418 2021 Equity Incentive Plan: Options and RSUs outstanding 14,318 Shares reserved for future award issuances 64,223 2022 Inducement Plan: Options and RSUs outstanding 3,076 Shares reserved for future award issuances 6,700 2021 Employee Stock Purchase Plan Shares reserved for future award issuances 10,798 Total shares of common stock reserved for issuance 113,533 2021 Employee Stock Purchase Plan Under the ESPP, the price at which common stock is purchased is equal to 85% of the fair market value of a share of the Company’s common stock on the first day of the offering period or the applicable purchase date, whichever is lower. The fair market value of common stock will generally be the closing sales price on the determination date. The ESPP provides an offering period of 24 months, with four purchase periods that are generally six months long and end on May 15 and November 15 of each year, except for the first purchase period, which began upon the completion of the IPO in September 2021 and ended on May 13, 2022. During the nine months ended September 30, 2023 and September 30, 2022, the Company issued 367,319 and 510,093 shares under the ESPP, respectively, in each case net of shares withheld and retired to satisfy withholding tax requirements for certain employees in jurisdictions outside the United States. The weighted average purchase price was $11.87 with net proceeds of $4.3 million in the nine months ended September 30, 2023, and the weighted average purchase price was $13.76 with net proceeds of $7.0 million in the nine months ended September 30, 2022. The ESPP also includes a reset provision for the purchase price if the fair market value of a share of the Company's common stock on the first day of any purchase period is less than or equal to the fair market value of a share of the Company's common stock on the first day of an ongoing offering. If the reset provision is triggered, a new 24-month offering period begins. The reset provision under the ESPP was triggered on May 16, 2022, and again on November 16, 2022. Each triggering of the reset provision was considered a modification in accordance with ASC 718, Stock Based Compensation , with the modification charge recognized on a straight-line basis over the new offering period. The previous modifications did not have a material effect on the Company's stock-based compensation expense during the three and nine months ended September 30, 2023. Stock-based compensation expense related to ESPP was $1.5 million and $2.2 million for the three months ended September 30, 2023 and 2022, respectively, and $6.0 million and $9.4 million for the nine months ended September 30, 2023 and 2022, respectively. Determination of Fair Value of the ESPP The Company estimates the fair value of the ESPP using the Black-Scholes option-pricing model, which requires certain complex valuation assumption inputs such as expected term, expected stock price volatility, risk-free interest rate, and dividend yield. The fair value of each of the four purchase periods is estimated separately. The following table summarizes the range of valuation assumptions used in estimating the fair value of the ESPP during the period: Valuation Assumption Inputs Nine Months Ended September 30, 2023 Nine Months Ended September 30, 2022 Expected term (in years) 0.5 - 1.5 0.5 - 2.0 Stock price volatility 58.1% - 77.3% 55.8% - 84.5% Risk-free interest rate 4.47% - 5.26% 1.54% - 2.58% Dividend yield —% —% Stock Options Stock options are generally granted with an exercise price equal to the fair market value of a share of common stock on the date of grant, have a 10-year contractual term, and vest over a four-year period. Share Information: Number of Shares (in thousands) Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term (in years) Aggregate Intrinsic Value (in thousands) (1) Balance as of December 31, 2022 2,758 $ 9.06 7.3 $ 15,595 Stock options exercised (205) $ 0.30 Stock options cancelled / forfeited / expired (3) $ 0.16 Balance as of September 30, 2023 2,550 $ 9.77 6.9 $ 25,883 Options vested and expected to vest as of September 30, 2023 2,550 $ 9.77 6.9 $ 25,883 Options exercisable as of September 30, 2023 1,188 $ 5.37 4.6 $ 17,289 (1) Aggregate intrinsic value for stock options represents the difference between the exercise price and the per share fair value of the Company’s common stock as of the end of the period, multiplied by the number of stock options outstanding, exercisable, or vested. Restricted Stock Units RSUs are granted at fair market value at the date of the grant and typically vest over a four-year period. RSU activity, which includes PRSUs, during the nine months ended September 30, 2023 is as follows: Share Information: Number of Shares Weighted-Average Grant Date Fair Value Per Share (in thousands, except per share data) Unvested, as of December 31, 2022 32,253 $ 18.86 Granted 9,164 $ 14.04 Vested (1) (8,350) $ 16.42 Forfeited (3,805) $ 17.31 Unvested, as of September 30, 2023 29,262 $ 18.25 (1) During the nine months ended September 30, 2023, total shares that vested were 8.3 million, of which 3.2 million were withheld for tax purposes. The total fair value of vested RSUs during the three months ended September 30, 2023 and 2022 was $50.7 million and $42.4 million, respectively. For the nine months ended September 30, 2023 and 2022, the total fair value of vested RSUs was $137.1 million and $191.4 million, respectively. Performance-Based Awards In May 2019, the Board approved a grant of 166,390 shares of PRSUs to the Company’s Chief Executive Officer (CEO). The vesting of these PRSUs is contingent upon the satisfaction of certain milestones. The revenue-related milestone and the liquidity event condition were met prior to December 31, 2021. As of September 30, 2023, the time-based vesting was the only condition yet to be satisfied over the remaining requisite service period, and the number of shares to vest subject to this condition is insignificant. In September 2021, the Board approved a grant of 6,000,000 PRSUs to the Company's CEO with a time-based service condition beginning January 1, 2022, and a market condition involving five separate stock price targets ranging from $70.00 to $200.00 per share for each of the five vesting tranches (CEO Performance Award). These stock price targets will be measured based on the average closing price over a consecutive 60-trading day period, beginning on the first trading day after the expiration of the final lock-up period in February 2022. The vesting of the CEO Performance Award is contingent upon the completion of the requisite service through January 1, 2029 and the achievement of the specified stock price target in each tranche on or before January 1, 2029. The stock price targets are not required to be achieved within the service period of each tranche, and accordingly, multiple tranches can vest at the same date if the specified stock price targets are achieved after December 31, 2025. The CEO Performance Award had a total grant date fair value of $131.0 million. The fair value of the CEO Performance Award was determined at grant date by using the Monte Carlo simulation model, which requires certain complex valuation assumption inputs such as measurement period, expected stock price volatility, risk-free interest rate and dividend yield. The Company recognized stock-based compensation expense associated with PRSUs granted to the CEO of $7.1 million for each of the three months ended September 30, 2023 and 2022; and $21.0 million each for the nine months ended September 30, 2023 and 2022. These expenses were recorded in general and administrative expenses in the condensed consolidated statements of operations. Stock-Based Compensation Total stock-based compensation expense recorded for the three and nine months ended September 30, 2023 and 2022 was as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Cost of revenue $ 1,710 $ 1,772 $ 5,137 $ 5,212 Research and development 9,623 10,318 28,662 26,446 Sales and marketing (1) 18,757 16,635 51,786 44,204 General and administrative (2) 25,035 25,167 74,482 74,790 Stock-based compensation, net of amounts capitalized 55,125 53,892 160,067 150,652 Capitalized stock-based compensation 484 52 1,422 1,275 Total stock-based compensation expense $ 55,609 $ 53,944 $ 161,489 $ 151,927 (1) Sales and marketing expense includes $2.4 million and $7.1 million for the three and nine months ended September 30, 2023, respectively, of stock-based compensation expense related to RSUs, options and ESPP purchase rights granted to the President of the Company primarily granted in September 2022. Stock-based compensation expense related to awards granted to the President were not material during the three and nine months ended September 30, 2022. (2) General and administrative expense includes stock-based compensation expense associated with RSUs and PRSUs granted to our CEO primarily in September 2021 of $14.1 million for each of the three months ended September 30, 2023 and 2022, and $41.8 million for each of the nine months ended September 30, 2023 and 2022. As of September 30, 2023, unrecognized stock-based compensation expense related to unvested stock-based awards was as follows (in thousands, except for period data): September 30, 2023 Unrecognized Stock-Based Compensation Weighted-Average Period to Recognize Expense RSUs and PRSUs $ 441,719 2.8 Stock options 10,955 2.9 ESPP 5,750 0.8 Total unrecognized stock-based compensation expense $ 458,424

Net Loss Per Share

Net Loss Per Share	9 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Net Loss Per Share	9. Net Loss Per Share Basic net loss per share attributable to common stockholders is computed by dividing the net loss by the number of weighted-average outstanding common shares. Diluted net loss per share attributable to common stockholders is determined by giving effect to all potential common equivalents during the reporting period, unless including them yields an antidilutive result. The Company considers its stock options and RSUs as potential common stock equivalents, but excluded them from the computation of diluted net loss per share attributable to common stockholders for the three and nine months ended September 30, 2023 and 2022, as their effect was antidilutive. The rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock are identical, except with respect to voting, conversion, and transfer rights. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis to each class of common stock and the resulting basic and diluted net loss per share attributable to common stockholders, are the same for both Class A and Class B common stock on both an individual and combined basis. The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Numerator: Net loss $ (31,033) $ (57,843) $ (109,355) $ (176,655) Denominator: Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders - basic and diluted 294,146 286,697 292,103 283,258 Net loss per share attributable to Class A and Class B common stockholders - basic and diluted $ (0.11) $ (0.20) $ (0.37) $ (0.62) The following table summarizes the potential common equivalents that were excluded from the computation of diluted net loss per share attributable to Class A and Class B common stockholders for the periods presented (in thousands): Three and Nine Months Ended September 30, 2023 2022 RSUs and PRSUs 29,262 35,771 Stock options 2,550 2,781 ESPP 241 359 Total 32,053 38,911

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	10. Income Taxes The Company's quarterly tax provision and estimates of its annual effective tax rate are estimates due to several factors, including changes in pre-tax income (or loss), the mix of jurisdictions to which such income relates, discrete items (such as windfalls or shortfalls from stock-based compensation) in the period offset with our valuation allowance. The provision for income taxes was $3.3 million

Geographic Information

Geographic Information	9 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
Geographic Information	11. Geographic Information The following table summarizes revenue by geographic location (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 North America $ 68,847 $ 56,288 $ 194,158 $ 157,178 Europe, Middle East and Africa 59,128 49,786 168,332 143,169 Asia Pacific 21,111 19,296 61,497 55,015 Other 4,464 3,390 12,334 9,467 Total revenue $ 153,550 $ 128,760 $ 436,321 $ 364,829 Revenue from North America consists primarily of revenue from the United States. For the three months ended September 30, 2023 and 2022, revenue generated from the United States was $60.1 million and $49.7 million, or approximately 38% and 39% of total consolidated revenue, respectively. For the nine months ended September 30, 2023 and 2022, revenue generated from the United States was $171.3 million and $138.7 million, or approximately 39% and 38% of total consolidated revenue, respectively. The United Kingdom, included within Europe, Middle East and Africa in the table above, contributed $19.4 million and $16.3 million, or approximately 12% and 13% of total consolidated revenue for the three months ended September 30, 2023 and 2022, respectively. For the nine months ended September 30, 2023 and 2022, the United Kingdom, included within Europe, Middle East and Africa in the table above, contributed $54.9 million and $47.0 million, or approximately 12% and 13% of total consolidated revenue, respectively. Long-lived assets consist primarily of property, plant and equipment and ROU assets. The following table summarizes long-lived assets by geographic information (in thousands): September 30, 2023 December 31, 2022 North America $ 23,627 $ 23,839 Europe, Middle East and Africa 2,652 4,039 Asia Pacific 28,895 29,285 Total long-lived assets $ 55,174 $ 57,163 Long-lived assets in North America are primarily located in the United States, and long lived assets in Asia Pacific are primarily located in India.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Pay vs Performance Disclosure
Net loss	$ (31,033)	$ (57,843)	$ (109,355)	$ (176,655)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	9 Months Ended
	Sep. 30, 2023 shares	Sep. 30, 2023 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		During the three months ended September 30, 2023, our officers (as defined in Rule 16a-1(f) under the Exchange Act) and directors adopted or terminated the contracts, instructions or written plans for the purchase or sale of the Company's securities, each of which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, as set forth in the table below. Name Title Action Adoption Date Expiration Date Total number of securities to be sold Tyler Sloat Chief Financial Officer Adoption September 6, 2023 August 31, 2024 Up to 400,000 shares Sameer Gandhi Director Adoption (1) September 19, 2023 November 29, 2024 Up to 100,000 shares (1) Barry Padgett Director Adoption September 14, 2023 September 3, 2024 Up to 38,356 shares (1) This 10b5-1 trading arrangement was adopted by The Potomac Trust, dated 9/21/2001, of which Mr. Gandhi is a co-trustee.
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Tyler Sloat [Member]
Trading Arrangements, by Individual
Name	Tyler Sloat
Title	Chief Financial Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 6, 2023
Arrangement Duration	360 days
Aggregate Available	400,000	400,000
Sameer Gandhi [Member]
Trading Arrangements, by Individual
Name	Sameer Gandhi
Title	Director
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 19, 2023
Arrangement Duration	437 days
Aggregate Available	100,000	100,000
Barry Padgett [Member]
Trading Arrangements, by Individual
Name	Barry Padgett
Title	Director
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 14, 2023
Arrangement Duration	355 days
Aggregate Available	38,356	38,356

Business, Basis of Presentati_2

Business, Basis of Presentation and Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Principles of Consolidation	The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP). The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, and all intercompany balances and transactions have been eliminated in consolidation.
Unaudited Interim Consolidated Financial Statements	The accompanying condensed consolidated balance sheet as of September 30, 2023, the condensed consolidated statements of operations, of comprehensive loss, of cash flows, and of stockholders’ equity for the three and nine months ended September 30, 2023 and 2022, and the related notes to such condensed consolidated financial statements are unaudited. These unaudited condensed consolidated financial statements are presented in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (SEC) and do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with GAAP. In management’s opinion, the unaudited condensed consolidated financial statements have been prepared on a basis consistent with the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of September 30, 2023 and its results of operations and cash flows for the three and nine months ended September 30, 2023 and 2022. The results of operations for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period. The condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the SEC on February 23, 2023.
Use of Estimates	The preparation of the condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of income and expense during the reporting periods. Significant items subject to such estimates and assumptions include, but are not limited to, the following: • determination of standalone selling price (SSP) for each distinct performance obligation included in customer contracts with multiple performance obligations; • allowance for doubtful accounts; • expected benefit period of deferred contract acquisition costs; • capitalization of internal-use software development costs; • fair value of goodwill; • useful lives of long-lived assets; • valuation of deferred tax assets; • valuation of employee defined benefit plan; • fair value of share-based awards, including performance-based awards; and • incremental borrowing rate used for operating leases.
Concentrations of Risk	Financial instruments that potentially expose the Company to significant concentration of credit risk consist primarily of cash, cash equivalents, marketable securities, and accounts receivable. The Company’s cash, cash equivalents and marketable securities are generally held with large financial institutions and are in excess of the federally insured limits provided on such deposits. In addition, the Company has cash and cash equivalents held in international bank accounts, which are denominated primarily in Euros, British Pounds, and Indian Rupees. There were no customers that individually exceeded 10% of the Company’s revenue for the three and nine months ended September 30, 2023 and 2022 or that represented 10% or more of the Company’s consolidated accounts receivable balance as of September 30, 2023. The Company primarily relies upon its third-party cloud infrastructure partner, Amazon Web Services, to serve customers and operate certain aspects of its services. Any disruption of this cloud infrastructure partner would impact the Company's operations and its business could be adversely impacted.
Derivative Instruments	The Company enters into foreign currency forward contracts, most of which were designated as cash flow hedges, in order to manage the volatility of cash flows that relate to cost of revenues and operating expenses denominated in Indian Rupee. All derivative instruments are measured at fair value based upon quoted market prices for comparable instruments and as such, classified within Level 2 of the fair value hierarchy. Derivative assets and liabilities are presented on a gross basis on the condensed consolidated balance sheets under prepaid expenses and other current assets and accrued liabilities, respectively. Gains or losses related to cash flow hedges are recorded as a component of accumulated other comprehensive income (AOCI) on the condensed consolidated statements of stockholders' equity until the forecasted transaction occurs in earnings. When the forecasted transaction occurs, the related gains and losses are reclassified into earnings within the financial statement line item associated with the underlying hedged transaction. If the underlying hedged transaction does not occur, or it becomes probable that the hedged transaction will not occur, the cumulative unrealized gain or loss is reclassified immediately from AOCI into earnings within interest and other income. Changes in the fair value of currency forward exchange contracts due to changes in time value were excluded from the assessment of effectiveness. The initial value of this excluded component is amortized on a straight-line basis over the life of the hedging instrument and recognized in the f inancial statement line item to which the hedge relates. A majority of the balance related to foreign exchange derivative instruments included in AOCI at September 30, 2023 is expected to be reclassified into earnings within 12 months. Derivative instruments are classified in the condensed consolidated statements of cash flows as cash from operating activities, which reflect the classification of the underlying hedged transactions. The Company does not use derivative financial instruments for trading or speculative purposes. As of September 30, 2023, the total notional amount of outstanding designated foreign currency forward contracts was $49.4 million. The fair value of derivative assets and liabilities as of September 30, 2023, and all related unrealized and realized gains and losses during the three and nine months ended September 30, 2023, were not material. Entering into derivative instruments exposes the Company to credit risk to the extent that the counterparties are unable to meet the terms of the contract. The Company mitigates this credit risk by transacting with major financial institutions with high credit ratings. In addition, the Company has entered into master netting arrangements that mitigate credit risk by permitting net settlement of transactions. As such, the Company's exposure is not considered significant. The Company does not have any collateral requirements with its counterparties.
Recent Accounting Pronouncements	There have been no recently issued accounting pronouncements that are expected to have a material impact on the Company's condensed consolidated financial statements.
Revenue From Contracts with Customers	The Company derives revenue from subscription fees and related professional services. The Company sells subscriptions for its cloud-based solutions directly to customers and indirectly through channel partners through arrangements that are non-cancelable and non-refundable. The Company’s subscription arrangements do not provide customers with the right to take possession of the software supporting the solutions and, as a result, are accounted for as service arrangements. The Company records revenue net of sales or value-added taxes.
Fair Value Measurements	The Company measures its financial assets at fair value each reporting period using a fair value hierarchy that prioritizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows: Level 1 —Inputs are observable and reflect quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 —Inputs other than quoted prices included within Level 1 that are observable, either directly or indirectly. Level 3 —Inputs that are unobservable.

Revenue From Contracts with C_2

Revenue From Contracts with Customers (Tables)	9 Months Ended
	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenues	The following table summarizes revenue by the Company’s service offerings (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Subscription services $ 150,033 $ 125,508 $ 425,755 $ 355,298 Professional services 3,517 3,252 10,566 9,531 Total revenue $ 153,550 $ 128,760 $ 436,321 $ 364,829
Summary of Changes in the Balance of Deferred Contract Acquisition Costs	The change in the balance of deferred contract acquisition costs during the periods presented is as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Balance at beginning of the period $ 40,962 $ 33,592 $ 39,675 $ 29,647 Add: Contract costs capitalized during the period 6,391 6,913 19,147 19,554 Less: Amortization of contract costs during the period (6,131) (4,625) (17,600) (13,321) Balance at end of the period $ 41,222 $ 35,880 $ 41,222 $ 35,880

Cash Equivalents and Marketab_2

Cash Equivalents and Marketable Securities (Tables)	9 Months Ended
	Sep. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Schedule of Available-for-sale Securities Reconciliation	Cash equivalents and available-for-sale debt securities consisted of the following as of September 30, 2023 and December 31, 2022 (in thousands): September 30, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Money market funds $ 99,040 $ — $ — $ 99,040 U.S. treasury securities 213,036 26 — 213,062 U.S. government agency securities 3,939 — — 3,939 Corporate debt securities 50,965 — — 50,965 Total cash equivalents 366,980 26 — 367,006 Debt securities: U.S. treasury securities 240,562 10 (1,197) 239,375 U.S. government agency securities 411,279 — (2,707) 408,572 Corporate debt securities 57,367 — (395) 56,972 Total debt securities 709,208 10 (4,299) 704,919 Total cash equivalents and debt securities $ 1,076,188 $ 36 $ (4,299) $ 1,071,925 December 31, 2022 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Money market funds $ 219,512 $ — $ — $ 219,512 U.S. treasury securities 13,912 3 — 13,915 U.S. government agency securities 10,417 2 — 10,419 Corporate debt securities 1,995 1 — 1,996 Total cash equivalents 245,836 6 — 245,842 Debt securities: U.S. treasury securities 441,909 36 (3,160) 438,785 U.S. government agency securities 301,009 35 (3,531) 297,513 Corporate debt securities 106,436 — (817) 105,619 Total debt securities 849,354 71 (7,508) 841,917 Total cash equivalents and debt securities $ 1,095,190 $ 77 $ (7,508) $ 1,087,759
Schedule of Available-for-Sale, Unrealized Loss Position, Fair Value	The following table presents gross unrealized losses and fair values for the securities that were in a continuous unrealized loss position as of September 30, 2023 and December 31, 2022 (in thousands): September 30, 2023 Less than 12 months Greater than 12 months Total Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury securities $ 103,977 $ (584) $ 51,150 $ (613) $ 155,127 $ (1,197) U.S. government agency securities 291,639 (1,588) 111,008 (1,119) 402,647 (2,707) Corporate debt securities 24,336 (228) 14,803 (167) 39,139 (395) Total $ 419,952 $ (2,400) $ 176,961 $ (1,899) $ 596,913 $ (4,299) December 31, 2022 Less Than 12 Months 12 Months or Greater Total Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury securities $ 190,820 $ (1,794) $ 105,115 $ (1,366) $ 295,935 $ (3,160) U.S. government agency securities 220,766 (2,245) 42,754 (1,286) 263,520 (3,531) Corporate debt securities 30,485 (455) 22,864 (362) 53,349 (817) Total $ 442,071 $ (4,494) $ 170,733 $ (3,014) $ 612,804 $ (7,508)
Schedule of Amortized Costs and Fair Value of Debt Securities Based on Contractual Maturities	The amortized cost and fair value of the available-for-sale debt securities based on contractual maturities are as follows (in thousands): September 30, 2023 Amortized Cost Fair Value Due within one year $ 485,733 $ 482,997 Due after one year but within five years 223,475 221,922 Total $ 709,208 $ 704,919

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following table represents the fair value hierarchy for the Company’s financial assets measured at fair value on a recurring basis as of September 30, 2023 and December 31, 2022 (in thousands): September 30, 2023 Fair Value Measured Using Level 1 Level 2 Total Financial assets: Cash equivalents: Money market funds $ 99,040 $ — $ 99,040 U.S. treasury securities 213,062 — 213,062 U.S. government agency securities — 3,939 3,939 Corporate debt securities — 50,965 50,965 Marketable securities: U.S. treasury securities 239,375 — 239,375 U.S. government agency securities — 408,572 408,572 Corporate debt securities — 56,972 56,972 Term bond mutual funds — 1,553 1,553 Total financial assets $ 551,477 $ 522,001 $ 1,073,478 December 31, 2022 Fair Value Measured Using Level 1 Level 2 Total Financial assets: Cash equivalents: Money market funds $ 219,512 $ — $ 219,512 U.S. treasury securities 13,915 — 13,915 U.S. government agency securities — 10,419 10,419 Corporate debt securities — 1,996 1,996 Marketable securities: U.S. treasury securities 438,785 — 438,785 U.S. government agency securities — 297,513 297,513 Corporate debt securities — 105,619 105,619 Term bond mutual funds — 1,488 1,488 Total financial assets $ 672,212 $ 417,035 $ 1,089,247

Balance Sheet Components (Table

Balance Sheet Components (Tables)	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Property, Plant and Equipment	The following table summarizes property and equipment, net as of September 30, 2023 and December 31, 2022 (in thousands): September 30, 2023 December 31, 2022 Computers $ 16,743 $ 16,552 Capitalized internal-use software 26,728 20,230 Office equipment 4,096 3,744 Furniture and fixtures 8,886 8,881 Motor vehicles 872 1,158 Leasehold improvements 5,729 5,654 Construction in progress 159 224 Total property and equipment 63,213 56,443 Less: accumulated depreciation and amortization (40,285) (32,304) Property and equipment, net $ 22,928 $ 24,139
Schedule of Accrued Liabilities	Accrued Liabilities The following table summarizes accrued liabilities as of September 30, 2023 and December 31, 2022 (in thousands): September 30, 2023 December 31, 2022 Accrued compensation $ 18,239 $ 20,192 Accrued third-party cloud infrastructure expenses — 2,752 Accrued reseller commissions 8,434 7,731 Accrued advertising and marketing expenses 3,902 4,465 Advanced payments from customers 4,295 3,480 Accrued taxes 8,242 7,730 Operating lease liabilities, current 3,862 6,775 Contributions withheld for employee stock purchase plan 2,854 1,546 Other accrued expenses 4,836 4,337 Total accrued liabilities $ 54,664 $ 59,008

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2023
Leases [Abstract]
Lease, Cost	The following table presents various components of the lease costs (in thousands): Operating Leases Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Operating lease cost $ 2,652 $ 2,147 $ 7,644 $ 6,026 Short-term lease cost 76 250 322 907 Variable lease cost 823 660 2,394 2,098 The weighted-average remaining term of the Company's operating leases and the weighted-average discount rate used to measure the present value of the operating lease liabilities are as follows: Lease Term and Discount Rate September 30, 2023 September 30, 2022 Weighted-average remaining lease term (in years) 5.1 5.0 Weighted-average discount rate 8.7 % 7.3 % The following table presents supplemental information arising from lease transactions. Cash payments related to short-term leases are not included in the measurement of the operating lease liabilities, and as such, are excluded from the amounts below (in thousands): Three Months Ended September 30, Nine Months Ended September 30, Supplemental Cash Flow Information: 2023 2022 2023 2022 Cash payments included in the measurement of operating lease liabilities $ 4,472 $ 3,126 $ 10,879 $ 7,400 Operating right-of-use ("ROU") assets obtained in exchange for lease obligations 4,914 1,749 4,914 8,968
Lessee, Operating Lease, Liability, Maturity	As of September 30, 2023, maturities of the operating lease liabilities are as follows (in thousands): Operating Leases Remainder of 2023 $ 253 2024 8,675 2025 9,555 2026 6,356 2027 5,131 Thereafter 10,417 Total lease payments 40,387 Less: imputed interest (9,576) Present value of operating lease liabilities $ 30,811

Stockholders' Equity and Stoc_2

Stockholders' Equity and Stock Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Summary of Common Shares Reserved for Future Issuance	Shares of common stock reserved for future issuance were as follows (in thousands): September 30, 2023 2011 Stock Plan: Options, RSUs and PRSUs outstanding 14,418 2021 Equity Incentive Plan: Options and RSUs outstanding 14,318 Shares reserved for future award issuances 64,223 2022 Inducement Plan: Options and RSUs outstanding 3,076 Shares reserved for future award issuances 6,700 2021 Employee Stock Purchase Plan Shares reserved for future award issuances 10,798 Total shares of common stock reserved for issuance 113,533
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions	The following table summarizes the range of valuation assumptions used in estimating the fair value of the ESPP during the period: Valuation Assumption Inputs Nine Months Ended September 30, 2023 Nine Months Ended September 30, 2022 Expected term (in years) 0.5 - 1.5 0.5 - 2.0 Stock price volatility 58.1% - 77.3% 55.8% - 84.5% Risk-free interest rate 4.47% - 5.26% 1.54% - 2.58% Dividend yield —% —%
Schedule of Stock Option Activity	Share Information: Number of Shares (in thousands) Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term (in years) Aggregate Intrinsic Value (in thousands) (1) Balance as of December 31, 2022 2,758 $ 9.06 7.3 $ 15,595 Stock options exercised (205) $ 0.30 Stock options cancelled / forfeited / expired (3) $ 0.16 Balance as of September 30, 2023 2,550 $ 9.77 6.9 $ 25,883 Options vested and expected to vest as of September 30, 2023 2,550 $ 9.77 6.9 $ 25,883 Options exercisable as of September 30, 2023 1,188 $ 5.37 4.6 $ 17,289 (1) Aggregate intrinsic value for stock options represents the difference between the exercise price and the per share fair value of the Company’s common stock as of the end of the period, multiplied by the number of stock options outstanding, exercisable, or vested.
Schedule of Restricted Stock Unit Activity	RSU activity, which includes PRSUs, during the nine months ended September 30, 2023 is as follows: Share Information: Number of Shares Weighted-Average Grant Date Fair Value Per Share (in thousands, except per share data) Unvested, as of December 31, 2022 32,253 $ 18.86 Granted 9,164 $ 14.04 Vested (1) (8,350) $ 16.42 Forfeited (3,805) $ 17.31 Unvested, as of September 30, 2023 29,262 $ 18.25
Stock-based Compensation Expense	Total stock-based compensation expense recorded for the three and nine months ended September 30, 2023 and 2022 was as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Cost of revenue $ 1,710 $ 1,772 $ 5,137 $ 5,212 Research and development 9,623 10,318 28,662 26,446 Sales and marketing (1) 18,757 16,635 51,786 44,204 General and administrative (2) 25,035 25,167 74,482 74,790 Stock-based compensation, net of amounts capitalized 55,125 53,892 160,067 150,652 Capitalized stock-based compensation 484 52 1,422 1,275 Total stock-based compensation expense $ 55,609 $ 53,944 $ 161,489 $ 151,927 (1) Sales and marketing expense includes $2.4 million and $7.1 million for the three and nine months ended September 30, 2023, respectively, of stock-based compensation expense related to RSUs, options and ESPP purchase rights granted to the President of the Company primarily granted in September 2022. Stock-based compensation expense related to awards granted to the President were not material during the three and nine months ended September 30, 2022.
Share-based Payment Arrangement, Nonvested Award, Cost	As of September 30, 2023, unrecognized stock-based compensation expense related to unvested stock-based awards was as follows (in thousands, except for period data): September 30, 2023 Unrecognized Stock-Based Compensation Weighted-Average Period to Recognize Expense RSUs and PRSUs $ 441,719 2.8 Stock options 10,955 2.9 ESPP 5,750 0.8 Total unrecognized stock-based compensation expense $ 458,424

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	9 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Numerator: Net loss $ (31,033) $ (57,843) $ (109,355) $ (176,655) Denominator: Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders - basic and diluted 294,146 286,697 292,103 283,258 Net loss per share attributable to Class A and Class B common stockholders - basic and diluted $ (0.11) $ (0.20) $ (0.37) $ (0.62)
Schedule of Potential Common Equivalents Excluded from Computation of Diluted Net Loss per Share	The following table summarizes the potential common equivalents that were excluded from the computation of diluted net loss per share attributable to Class A and Class B common stockholders for the periods presented (in thousands): Three and Nine Months Ended September 30, 2023 2022 RSUs and PRSUs 29,262 35,771 Stock options 2,550 2,781 ESPP 241 359 Total 32,053 38,911

Geographic Information (Tables)

Geographic Information (Tables)	9 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
Schedule of Revenue and Long-Lived Assets by Geographical Region	The following table summarizes revenue by geographic location (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 North America $ 68,847 $ 56,288 $ 194,158 $ 157,178 Europe, Middle East and Africa 59,128 49,786 168,332 143,169 Asia Pacific 21,111 19,296 61,497 55,015 Other 4,464 3,390 12,334 9,467 Total revenue $ 153,550 $ 128,760 $ 436,321 $ 364,829 September 30, 2023 December 31, 2022 North America $ 23,627 $ 23,839 Europe, Middle East and Africa 2,652 4,039 Asia Pacific 28,895 29,285 Total long-lived assets $ 55,174 $ 57,163

Business, Basis of Presentati_3

Business, Basis of Presentation and Summary of Significant Accounting Policies (Details) $ in Millions	Sep. 30, 2023 USD ($)
Foreign Exchange Forward
Derivative [Line Items]
Notional amount	$ 49.4

Revenue From Contracts with C_3

Revenue From Contracts with Customers - Disaggregation of Revenues (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 153,550	$ 128,760	$ 436,321	$ 364,829
Subscription services
Disaggregation of Revenue [Line Items]
Revenue	150,033	125,508	425,755	355,298
Professional services
Disaggregation of Revenue [Line Items]
Revenue	$ 3,517	$ 3,252	$ 10,566	$ 9,531

Revenue From Contracts with C_4

Revenue From Contracts with Customers - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue recognized during the period	$ 109,500	$ 86,200	$ 192,600	$ 146,900
Remaining performance obligation	375,800		375,800
Deferred revenue	246,085		246,085		$ 205,626
Unbilled Revenue	129,700		129,700
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation	$ 285,000		$ 285,000
Remaining performance obligation, expected timing of satisfaction, period	12 months		12 months

Revenue From Contracts with C_5

Revenue From Contracts with Customers - Deferred Contract Acquisition Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Change in Deferred Contract Acquisition Costs [Roll Forward]
Balance at beginning of the period	$ 40,962	$ 33,592	$ 39,675	$ 29,647
Add: Contract costs capitalized during the period	6,391	6,913	19,147	19,554
Less: Amortization of contract costs during the period	(6,131)	(4,625)	(17,600)	(13,321)
Balance at end of the period	$ 41,222	$ 35,880	$ 41,222	$ 35,880

Cash Equivalents and Marketab_3

Cash Equivalents and Marketable Securities - Schedule of Carrying Amounts and Fair Values of Debt Securities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Unrealized Gains	$ 36	$ 77
Unrealized Losses	(4,299)	(7,508)
Cash Equivalents and Available-for-sale Debt Securities
Amortized Cost	1,076,188	1,095,190
Fair Value	1,071,925	1,087,759
Cash Equivalents
Debt Securities, Available-for-sale [Line Items]
Unrealized Gains	26	6
Unrealized Losses	0	0
Cash Equivalents and Available-for-sale Debt Securities
Amortized Cost	366,980	245,836
Fair Value	367,006	245,842
Cash Equivalents | U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Debt securities, Amortized Cost	213,036	13,912
Unrealized Gains	26	3
Unrealized Losses	0	0
Fair Value	213,062	13,915
Cash Equivalents | U.S. government agency securities
Debt Securities, Available-for-sale [Line Items]
Debt securities, Amortized Cost	3,939	10,417
Unrealized Gains	0	2
Unrealized Losses	0	0
Fair Value	3,939	10,419
Cash Equivalents | Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Debt securities, Amortized Cost	50,965	1,995
Unrealized Gains	0	1
Unrealized Losses	0	0
Fair Value	50,965	1,996
Marketable Securities
Debt Securities, Available-for-sale [Line Items]
Debt securities, Amortized Cost	709,208	849,354
Unrealized Gains	10	71
Unrealized Losses	(4,299)	(7,508)
Fair Value	704,919	841,917
Marketable Securities | U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Debt securities, Amortized Cost	240,562	441,909
Unrealized Gains	10	36
Unrealized Losses	(1,197)	(3,160)
Fair Value	239,375	438,785
Marketable Securities | U.S. government agency securities
Debt Securities, Available-for-sale [Line Items]
Debt securities, Amortized Cost	411,279	301,009
Unrealized Gains	0	35
Unrealized Losses	(2,707)	(3,531)
Fair Value	408,572	297,513
Marketable Securities | Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Debt securities, Amortized Cost	57,367	106,436
Unrealized Gains	0	0
Unrealized Losses	(395)	(817)
Fair Value	56,972	105,619
Money market funds
Debt Securities, Available-for-sale [Line Items]
Cash Equivalents	$ 99,040	$ 219,512

Cash Equivalents and Marketab_4

Cash Equivalents and Marketable Securities - Schedule of Continuous Unrealized Loss Position and Fair Values of Debt Securities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Fair Value
Less than 12 months	$ 419,952	$ 442,071
Greater than 12 months	176,961	170,733
Total	596,913	612,804
Unrealized Loss
Less than 12 months	(2,400)	(4,494)
Greater than 12 months	(1,899)	(3,014)
Total	(4,299)	(7,508)
U.S. treasury securities
Fair Value
Less than 12 months	103,977	190,820
Greater than 12 months	51,150	105,115
Total	155,127	295,935
Unrealized Loss
Less than 12 months	(584)	(1,794)
Greater than 12 months	(613)	(1,366)
Total	(1,197)	(3,160)
U.S. government agency securities
Fair Value
Less than 12 months	291,639	220,766
Greater than 12 months	111,008	42,754
Total	402,647	263,520
Unrealized Loss
Less than 12 months	(1,588)	(2,245)
Greater than 12 months	(1,119)	(1,286)
Total	(2,707)	(3,531)
Corporate debt securities
Fair Value
Less than 12 months	24,336	30,485
Greater than 12 months	14,803	22,864
Total	39,139	53,349
Unrealized Loss
Less than 12 months	(228)	(455)
Greater than 12 months	(167)	(362)
Total	$ (395)	$ (817)

Cash Equivalents and Marketab_5

Cash Equivalents and Marketable Securities - Amortized Cost and Fair Value Based on Contractual Maturities (Details) - Marketable Securities - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Amortized Cost
Due within one year	$ 485,733
Due after one year but within five years	223,475
Debt securities, Amortized Cost	709,208	$ 849,354
Fair Value
Due within one year	482,997
Due after one year but within five years	221,922
Total	$ 704,919	$ 841,917

Cash Equivalents and Marketab_6

Cash Equivalents and Marketable Securities - Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Accrued interest	$ 4	$ 2.8
Mutual funds
Debt Securities, Available-for-sale [Line Items]
Equity securities	$ 1.6	$ 1.5

Fair Value Measurements - Asset

Fair Value Measurements - Assets and Liabilities Measured on Recurring Basis (Details) - Fair Value, Recurring - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total financial assets	$ 1,073,478	$ 1,089,247
U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	239,375	438,785
U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	408,572	297,513
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	56,972	105,619
Term bond mutual funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	1,553	1,488
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	99,040	219,512
U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	213,062	13,915
U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	3,939	10,419
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	50,965	1,996
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total financial assets	551,477	672,212
Level 1 | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	239,375	438,785
Level 1 | U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 1 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 1 | Term bond mutual funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 1 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	99,040	219,512
Level 1 | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	213,062	13,915
Level 1 | U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	0	0
Level 1 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total financial assets	522,001	417,035
Level 2 | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 2 | U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	408,572	297,513
Level 2 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	56,972	105,619
Level 2 | Term bond mutual funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	1,553	1,488
Level 2 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	0	0
Level 2 | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	0	0
Level 2 | U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	3,939	10,419
Level 2 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	$ 50,965	$ 1,996

Balance Sheet Components - Prop

Balance Sheet Components - Property, Plant, and Equipment (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 63,213	$ 56,443
Less: accumulated depreciation and amortization	(40,285)	(32,304)
Property and equipment, net	22,928	24,139
Computers
Property, Plant and Equipment [Line Items]
Total property and equipment	16,743	16,552
Capitalized internal-use software
Property, Plant and Equipment [Line Items]
Total property and equipment	26,728	20,230
Office equipment
Property, Plant and Equipment [Line Items]
Total property and equipment	4,096	3,744
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment	8,886	8,881
Motor vehicles
Property, Plant and Equipment [Line Items]
Total property and equipment	872	1,158
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment	5,729	5,654
Construction in progress
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 159	$ 224

Balance Sheet Components - Narr

Balance Sheet Components - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Capitalized costs	$ 2	$ 1.2	$ 6.5	$ 5.1
Amortization expense	1.3	0.9	3.7	2.4
Net carrying value	14		14		$ 11.2
Depreciation expense and amortization	1.7	$ 1.7	5.1	$ 4.9
Long-term accrued compensation	$ 21.3		$ 21.3		$ 23.3

Balance Sheet Components - Accr

Balance Sheet Components - Accrued Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued compensation	$ 18,239	$ 20,192
Accrued third-party cloud infrastructure expenses	0	2,752
Accrued reseller commissions	8,434	7,731
Accrued advertising and marketing expenses	3,902	4,465
Advanced payments from customers	4,295	3,480
Accrued taxes	8,242	7,730
Operating lease liabilities, current	3,862	6,775
Contributions withheld for employee stock purchase plan	2,854	1,546
Other accrued expenses	4,836	4,337
Accrued liabilities	$ 54,664	$ 59,008

Leases - Narrative (Details)

Leases - Narrative (Details)	Sep. 30, 2023
Lessee, Lease, Description [Line Items]
Operating lease, option to extend, term	6 years
Minimum
Lessee, Lease, Description [Line Items]
Operating lease, term	1 year
Maximum
Lessee, Lease, Description [Line Items]
Operating lease, term	9 years

Leases - Schedule of Lease Cost

Leases - Schedule of Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Leases [Abstract]
Operating lease cost	$ 2,652	$ 2,147	$ 7,644	$ 6,026
Short-term lease cost	76	250	322	907
Variable lease cost	$ 823	$ 660	$ 2,394	$ 2,098

Leases - Summary of Lease Term

Leases - Summary of Lease Term and Discount Rate (Details)	Sep. 30, 2023	Sep. 30, 2022
Leases [Abstract]
Weighted-average remaining lease term (in years)	5 years 1 month 6 days	5 years
Weighted-average discount rate	8.70%	7.30%

Leases - Summary of Supplementa

Leases - Summary of Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Leases [Abstract]
Cash payments included in the measurement of operating lease liabilities	$ 4,472	$ 3,126	$ 10,879	$ 7,400
Operating lease right-of-use assets obtained in exchange for operating lease obligations	$ 4,914	$ 1,749	$ 4,914	$ 8,968

Leases - Schedule of Maturities

Leases - Schedule of Maturities of Operating Lease Liabilities (Details) $ in Thousands	Sep. 30, 2023 USD ($)
Leases [Abstract]
Remainder of 2023	$ 253
2024	8,675
2025	9,555
2026	6,356
2027	5,131
Thereafter	10,417
Total lease payments	40,387
Less: imputed interest	(9,576)
Present value of operating lease liabilities	$ 30,811

Commitment and Contingencies (D

Commitment and Contingencies (Details) $ in Millions	Sep. 30, 2023 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Contractual commitments	$ 73.7

Stockholders' Equity and Stoc_3

Stockholders' Equity and Stock Based Compensation - Narrative (Details) $ / shares in Units, $ in Thousands	1 Months Ended		3 Months Ended		9 Months Ended
	Sep. 30, 2021 USD ($) tranche target $ / shares shares	May 31, 2019 shares	Sep. 30, 2023 USD ($) $ / shares	Sep. 30, 2022 USD ($) $ / shares	Sep. 30, 2023 USD ($) purchasePeriod $ / shares shares	Sep. 30, 2022 USD ($) $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of common stock under employee stock purchase plan, net of shares withheld for taxes (in shares) | shares					367,319	510,093
Proceeds from issuance of common stock under employee stock purchase plan, net					$ 4,312	$ 7,011
Share-based payment arrangement, expense			$ 55,125	$ 53,892	$ 160,067	$ 150,652
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Purchase price of common stock in percent					85%
Offering period					24 months
Number of purchase periods | purchasePeriod					4
Purchase period					6 months
Share-based compensation arrangement by share-based payment award, weighted average price of shares purchased (in USD per share) | $ / shares			$ 11.87	$ 13.76	$ 11.87	$ 13.76
Proceeds from issuance of common stock under employee stock purchase plan, net					$ 4,300	$ 7,000
ESPP offering period					24 months
Share-based payment arrangement, expense			$ 1,500	$ 2,200	$ 6,000	9,400
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Contractual term					10 years
Award vesting period					4 years
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period					4 years
Total grant date fair value of vested RSUs			50,700	42,400	$ 137,100	191,400
Granted (in shares) | shares					9,164,000
Performance Based Restricted Stock Units (PRSUs) | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, expense			$ 7,100	$ 7,100	$ 21,000	$ 21,000
Total grant date fair value of vested RSUs	$ 131,000
Granted (in shares) | shares	6,000,000	166,390
Number of threshold stock price targets | target	5
Number of threshold vesting tranches | tranche	5
Trading day period	60 days
Performance Based Restricted Stock Units (PRSUs) | Chief Executive Officer | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Threshold stock price target (in USD per share) | $ / shares	$ 70
Performance Based Restricted Stock Units (PRSUs) | Chief Executive Officer | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Threshold stock price target (in USD per share) | $ / shares	$ 200

Stockholders' Equity and Stoc_4

Stockholders' Equity and Stock Based Compensation - Shares of Common Stock Reserved for Future Issuance (Details) shares in Thousands	Sep. 30, 2023 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	113,533
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	10,798
2011 Stock Plan: | Share-Based Payment Arrangements
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	14,418
2021 Equity Incentive Plan:
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	64,223
2021 Equity Incentive Plan: | Share-Based Payment Arrangements
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	14,318
2022 Inducement Plan:
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	6,700
2022 Inducement Plan: | Share-Based Payment Arrangements
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	3,076

Stockholders' Equity and Stoc_5

Stockholders' Equity and Stock Based Compensation - Summary of ESPP Valuation Assumptions (Details) - ESPP	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock price volatility	58.10%	55.80%
Stock price volatility	77.30%	84.50%
Risk-free interest rate	4.47%	1.54%
Risk-free interest rate	5.26%	2.58%
Dividend yield	0%	0%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	6 months	6 months
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	1 year 6 months	2 years

Stockholders' Equity and Stoc_6

Stockholders' Equity and Stock Based Compensation - Summary of Stock Options (Details) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares
Number of Shares (in thousands)
Beginning balance (in shares) | shares	2,758
Stock options exercised (in shares) | shares	(205)
Stock options cancelled / forfeited / expired (in shares) | shares	(3)
Ending balance (in shares) | shares	2,550	2,758
Options vested or expected to vest (in shares) | shares	2,550
Options exercisable (in shares) | shares	1,188
Weighted-Average Exercise Price
Beginning balance (in USD per share) | $ / shares	$ 9.06
Stock options exercised (in USD per share) | $ / shares	0.30
Stock options cancelled / forfeited / expired (in USD per share) | $ / shares	0.16
Ending balance (in USD per share) | $ / shares	9.77	$ 9.06
Options vested or expected to vest (in USD per share) | $ / shares	9.77
Options exercisable (in USD per share) | $ / shares	$ 5.37
Weighted-Average Remaining Contractual Term (in years)
Weighted-Average Remaining Contractual Term (in years)	6 years 10 months 24 days	7 years 3 months 18 days
Options vested or expected to vest as of the end of the period	6 years 10 months 24 days
Options exercisable as of the end of the period	4 years 7 months 6 days
Aggregate Intrinsic Value
Aggregate intrinsic value | $	$ 25,883	$ 15,595
Options vested or expected to vest as of the end of the period | $	25,883
Options exercisable as of the end of the period | $	$ 17,289

Stockholders' Equity and Stoc_7

Stockholders' Equity and Stock Based Compensation - Schedule of Restricted Stock Unit Activity (Details) shares in Thousands	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Weighted-Average Grant Date Fair Value Per Share
Stock withheld for tax withholding requirements (in shares)	3,200
Restricted Stock Units
Number of Shares
Unvested, beginning balance (in shares)	32,253
Granted (in shares)	9,164
Vested (in shares)	(8,350)
Forfeited (in shares)	(3,805)
Unvested, ending balance (in shares)	29,262
Weighted-Average Grant Date Fair Value Per Share
Unvested, beginning balance (in USD per share) | $ / shares	$ 18.86
Granted (in USD per share) | $ / shares	14.04
Vested (in USD per share) | $ / shares	16.42
Forfeited (in USD per share) | $ / shares	17.31
Unvested, ending balance (in USD per share) | $ / shares	$ 18.25
Stock vested (in shares)	8,350

Stockholders' Equity and Stoc_8

Stockholders' Equity and Stock Based Compensation - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	$ 55,125	$ 53,892	$ 160,067	$ 150,652
Capitalized stock-based compensation	484	52	1,422	1,275
Total stock-based compensation expense	55,609	53,944	161,489	151,927
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	1,710	1,772	5,137	5,212
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	9,623	10,318	28,662	26,446
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	18,757	16,635	51,786	44,204
Sales and marketing | President
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	2,400	0	7,100	0
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	25,035	25,167	74,482	74,790
General and administrative | RSUs and PRSUs
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	$ 14,100	$ 14,100	$ 41,800	$ 41,800

Stockholders' Equity and Stoc_9

Stockholders' Equity and Stock Based Compensation - Schedule of Unrecognized Stock-Based Compensation (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2023 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense, including options	$ 10,955
Total unrecognized stock-based compensation expense	458,424
RSUs and PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense, excluding options	$ 441,719
Weighted-Average Period to Recognize Expense (in years)	2 years 9 months 18 days
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-Average Period to Recognize Expense (in years)	2 years 10 months 24 days
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense, excluding options	$ 5,750
Weighted-Average Period to Recognize Expense (in years)	9 months 18 days

Net Loss Per Share - Computatio

Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Numerator:
Net loss	$ (31,033)	$ (57,843)	$ (109,355)	$ (176,655)
Denominator:
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders - basic (in shares)	294,146	286,697	292,103	283,258
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders - diluted (in shares)	294,146	286,697	292,103	283,258
Net loss per share attributable to Class A and Class B common stockholders - diluted (in dollars per share)	$ (0.11)	$ (0.20)	$ (0.37)	$ (0.62)
Net loss per share attributable to Class A and Class B common stockholders - basic (in dollars per share)	$ (0.11)	$ (0.20)	$ (0.37)	$ (0.62)

Net Loss Per Share - Potential

Net Loss Per Share - Potential Common Equivalents Excluded from Computation of Diluted Net Loss per Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	32,053	38,911	32,053	38,911
RSUs and PRSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	29,262	35,771	29,262	35,771
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	2,550	2,781	2,550	2,781
ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	241	359	241	359

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 3,291	$ 1,804	$ 10,912	$ 6,500

Geographic Information - Schedu

Geographic Information - Schedule of Revenue and Long-lived Assets by Geographic Location (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 153,550	$ 128,760	$ 436,321	$ 364,829
Total long-lived assets	55,174		55,174		$ 57,163
North America
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	68,847	56,288	194,158	157,178
Total long-lived assets	23,627		23,627		23,839
Europe, Middle East and Africa
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	59,128	49,786	168,332	143,169
Total long-lived assets	2,652		2,652		4,039
Asia Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	21,111	19,296	61,497	55,015
Total long-lived assets	28,895		28,895		$ 29,285
Other
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 4,464	$ 3,390	$ 12,334	$ 9,467

Geographic Information - Additi

Geographic Information - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 153,550	$ 128,760	$ 436,321	$ 364,829
UNITED STATES
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 60,100	$ 49,700	$ 171,300	$ 138,700
UNITED STATES | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk percentage	38%	39%	39%	38%
UNITED KINGDOM
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 19,400	$ 16,300	$ 54,900	$ 47,000
UNITED KINGDOM | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk percentage	12%	13%	12%	13%